1,3-bis-(substituted-phenyl)-2-propyn-1-ones and their use to treat disorders
申请人:AtheroGenics, Inc.
公开号:US07202247B2
公开(公告)日:2007-04-10
The invention relates to compounds, pharmaceutical compositions and methods of using compounds of the general formula
or its pharmaceutically acceptable salt or ester, wherein the substituents are defined in the application.
Bis(arylmethylidene)acetone compound, anti-cancer agent, carcinogenesis-preventive agent, inhibitor of expression of Ki-Ras, ErbB2, c-Myc and Cycline D1, β-catenin-degrading agent, and p53 expression enhancer
申请人:National University Corporation Tohoku University
公开号:US08178727B2
公开(公告)日:2012-05-15
It has been demanded to improve the poor solubility of curcumin to develop an anti-tumor compound capable of inhibiting the growth of various cancer cells at a low concentration. Thus, disclosed is a novel synthetic compound, a bis(arylmethylidene)acetone, which has both of an excellent anti-tumor activity and a chemo-preventive activity. A bis(arylmethylidene)acetone (i.e., a derivative having a curcumin skeleton) which is an anti-tumor compound and has a chemo-preventive activity is synthesized and screened. A derivative having enhanced anti-tumor activity and chemo-preventive activity can be synthesized.
[EN] 1,3-BIS-(SUBSTITUTED-PHENYL)-2-PROPYN-1-ONES AND THEIR USE TO TREAT DISORDERS<br/>[FR] 1,3-BIS-(PHENYL-SUBSTITUE)-2-PROPYNE-1-ONES ET LEUR UTILISATION POUR LE TRAITEMENT D'AFFECTIONS
申请人:ATHEROGENICS INC
公开号:WO2003053359A2
公开(公告)日:2003-07-03
The invention relates to compounds, pharmaceutical compositions and the use of compounds of the general formula, or its pharmaceutically acceptable salt or ester, wherein the substituents are defined in the application.